Zions Bancorporation, National Association’s Catalyst Pharmaceutical CPRX Stock Holding History

Zions Bancorporation, National Association’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$94	Buy	+3	New	+$89	﹤0.01%	1617

Other funds holding CPRX

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

CIEC

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

CWP

Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return

Zions Bancorporation, National Association's CPRX Position: Q2 2026 in Review

Zions Bancorporation, National Association opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 3 shares worth $94. The stake represents ﹤0.01% of the portfolio and ranks #1617 among its holdings.

119 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Zions Bancorporation, National Association held 3 shares of Catalyst Pharmaceutical worth $94 as of Q2 2026.
Catalyst Pharmaceutical was a new Zions Bancorporation, National Association position in Q2 2026.
Catalyst Pharmaceutical made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1617 holding.
119 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.